The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Okitask 25 mg Film-Coated Tablets

25 milligram(s) Film-coated tablet

Dompé Farmaceutici S.p.A.PA23072/001/002

Main Information

Trade NameOkitask 25 mg Film-Coated Tablets
Active SubstancesKETOPROFEN LYSINE
Strength25 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderDompé Farmaceutici S.p.A.
Licence NumberPA23072/001/002

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE03 ketoprofen

Status

Authorised/WithdrawnAuthorised
Licence Issued12/04/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back